Overcoming reduced antibiotic susceptibility in intracellular Salmonella enterica serovar Typhimurium using AR-12.
Overcoming reduced antibiotic susceptibility in intracellular Salmonella enterica serovar Typhimurium using AR-12.
复制标题
使用 AR-12 克服细胞内肠沙门氏菌鼠伤寒血清型中抗生素敏感性降低的问题。
DOI:
10.1093/femsle/fnab062
复制
发表时间:
2021
影响因子:
2.1
通讯作者:
Ainslie,KristyM
中科院分区:
文献类型:
--
作者:
Zahid,MShamimHasan;Varma,DevikaM;Johnson,MonicaM;Landavazo,Antonio;Bachelder,EricM;Blough,BruceE;Ainslie,KristyM
Host-directed therapies (HDTs) could enhance the activity of traditional antibiotics. AR-12 is a promising HDT against intracellular pathogens includingSalmonella entericaserovar Typhimurium, and has been shown to act through modulation of autophagy and the Akt kinase pathway. Since AR-12 does not inhibit the growth of planktonic bacteria but only works in conjunction with the infected host-cell, we hypothesized that AR-12 could enhance the activity of antibiotics in less-susceptible strains in the intracellular host environment. We found that repetitive passaging ofS.typhimuriumin macrophages in the absence of antibiotics led to a 4-fold reduction in their intracellular susceptibility to streptomycin (STR), but had no effect on the bacteria's sensitivity to AR-12. Moreover, when the host-passaged strains were treated with a combined therapy of AR-12 and STR, there was a significant reduction of intracellular bacterial burden compared to STR monotherapy. Additionally, co-treatment of macrophages infected with multi-drug resistantS.typhimuriumwith AR-12 and STR or ampicillin showed enhanced clearance of the intracellular bacteria. The drug combination did not elicit this effect on planktonic bacteria. Overall, AR-12 enhanced the clearance of less susceptibleS.typhimuriumin an intracellular environment.